2m 2m 2m 2m 2m 2m 2m
SCIENTURE HLDGS (SCNX)
NASDAQ
$0.38-$0.01 (-3.30%)
Price as of Jun 03, 2026 6:50 PM EDT- $16.8MMarket Cap
- -53.63%1-Year Change
- Pharmaceutical RetailersIndustry
SCIENTURE HLDGS (SCNX)
$0.38-$0.01 (-3.30%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | 8.3M -27.74% | 11.4M +15.76% | |
Cost of Revenue | 100,127 -23.36% | 130,638 -97.70% | 5.7M -5.39% | 6.0M +16.60% | |
Gross Profit | 331,482 +353.74% | -130,638 -105.03% | 2.6M -52.34% | 5.5M +14.86% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -2.0M -12.54% | -2.2M N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 453,846 N/A | N/A N/A | 814,790 +5,466.65% | 14,637 +99.12% | |
Total Operating Expenses | 42.9M +191.85% | 14.7M +49.13% | 9.9M -0.14% | 9.9M -1.62% | |
Operating Profit | -42.6M +189.71% | -14.7M +102.40% | -7.3M +64.17% | -4.4M -16.40% | |
Interest Income | 302,702 +123.67% | 135,337 +3,123.84% | 4,198 -80.00% | 20,989 N/A | |
Interest Expense | -141,977 +325.94% | -33,333 -97.22% | -1.2M +256.43% | -336,206 +1,325.21% | |
Interest Income and Expense and Net | 160,725 +57.57% | 102,004 +108.54% | -1.2M +278.83% | -315,217 +1,236.23% | |
Total Nonoperating Income and Expense | -916,300 -77.53% | -4.1M -36.85% | -6.5M -1,355.21% | 514,427 +2,080.70% | |
Income before Taxes | -43.5M +131.68% | -18.8M +158.54% | -7.3M +64.17% | -4.4M -16.40% | |
Income Taxes | -2.0M +273.30% | -534,396 N/A | N/A N/A | N/A N/A | |
Extraordinary Items | 26.3M N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -41.5M +127.53% | -18.2M +2.25% | -17.8M +413.91% | -3.5M -34.68% | |
Net Income from Continuing Operations Applicable to Common | -41.5M +127.53% | -18.2M +32.97% | -13.7M +295.17% | -3.5M -34.68% | |
Basic EPS and Net Income | -2.70 -200.37% | 2.69 +111.52% | -23.35 +5,595.12% | -0.41 -36.92% | |
Diluted EPS and Net Income | -2.70 -208.87% | 2.48 +133.11% | -7.49 +1,726.83% | -0.41 -36.92% | |
Basic Weighted Average Shares | 15.3M +354.69% | 3.4M +341.76% | 764,058 -90.98% | 8.5M +4.13% | |
Diluted Weighted Average Shares | 15.3M +320.06% | 3.7M +53.42% | 2.4M -71.89% | 8.5M +4.13% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 6.7M +2,062.32% | 308,096 +102.82% | 151,908 -86.60% | 1.1M -63.70% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 6.7M +2,062.32% | 308,096 +102.82% | 151,908 -86.60% | 1.1M -63.70% | |
Total Current Assets | 7.9M +25.55% | 6.3M +129.04% | 2.8M +31.53% | 2.1M -52.15% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 15,500 -11.43% | 17,500 -93.68% | 277,009 +324.77% | 65,214 -33.96% | |
Total Long-Term Assets | 62,884 -88.61% | 552,300 +99.38% | 277,009 +324.77% | 65,214 -33.96% | |
Total Assets | 84.2M -19.72% | 104.9M +736.63% | 12.5M +237.81% | 3.7M -35.66% | |
Income Taxes Payable | 11.0M -18.39% | 13.5M N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 50.0M +1,751.56% | 2.7M -58.65% | 6.5M +3,817.99% | 166,667 N/A | |
Total Current Liabilities | 2.7M -65.41% | 7.9M -31.58% | 11.6M +438.31% | 2.1M +131.83% | |
Total Long-Term Debt | 720,000 +17.59% | 612,275 +2,349.10% | 25,000 -92.50% | 333,333 N/A | |
Total Long-Term Liabilities | 22.1M -27.40% | 30.4M +2,497.57% | 1.2M +32.03% | 887,035 -17.10% | |
Total Liabilities | 14.1M -45.47% | 25.8M +115.02% | 12.0M +256.10% | 3.4M +68.70% | |
Retained Earnings | -80.6M +106.34% | -39.0M +17.42% | -33.2M +68.59% | -19.7M +21.37% | |
Total Stockholders Equity | N/A N/A | 79.1M +14,479.46% | 542,353 -28.93% | 763,136 -79.76% | |
Total Shares Outstanding | 40.6M +364.32% | 8.8M +866.91% | 905,008 -90.37% | 9.4M +15.03% | |
Cash Flow | |||||
Cash from Operating Activities | -13.4M -6.21% | -14.3M +587.95% | -2.1M +35.89% | -1.5M -40.54% | |
Capital Expenditures | N/A N/A | 12,000 N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | N/A N/A | 27.6M +10,093.14% | -275,717 -35.56% | -427,845 +1,793.45% | |
Dividends Paid | N/A N/A | 14.9M N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 19.7M +252.03% | -13.0M -1,022.95% | 1.4M +4,098.56% | -35,171 -83.11% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | 31.41% -34.04% | 47.62% -0.78% | |
Operating Margin | N/A N/A | N/A N/A | -87.80% +127.20% | -38.65% -27.78% | |
Return on Assets | -43.92% +41.30% | -31.08% -85.85% | -219.71% +199.82% | -73.28% +7.24% | |
Return on Equity | N/A N/A | -45.83% -98.32% | -2,733.62% +1,684.56% | -153.18% +79.37% | |
Revenue Growth | N/A N/A | N/A N/A | -27.74% -276.00% | 15.76% +137.31% | |
Current Ratio | 2.89 +262.90% | 0.80 +234.80% | 0.24 -75.57% | 0.98 -79.36% | |
Cash Ratio | 2.44 +6,144.87% | 0.04 +197.71% | 0.01 -97.52% | 0.53 -84.34% | |
Debt-to-Equity Ratio | N/A N/A | 0.04 -99.65% | 12.09 +1,744.66% | 0.66 N/A | |
Debt-to-Assets Ratio | 0.60 +1,806.65% | 0.03 -93.96% | 0.52 +287.98% | 0.13 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow